Shareholders Equity and Capital Stock (Details 4) $ in Thousands |
9 Months Ended |
---|---|
Sep. 30, 2021
USD ($)
shares
| |
Number of unvested units | shares | 1,650,649 |
Remaining life (years) | 10 months 24 days |
Aggregate Intrinsic Value | $ | $ 2,839,117 |
November 06, 2021 [Member] | |
Number of unvested units | shares | 638,989 |
Remaining life (years) | 1 month 6 days |
Aggregate Intrinsic Value | $ | $ 1,099,061 |
Redemption date | Nov. 06, 2021 |
November 13, 2022 [Member] | |
Number of unvested units | shares | 706,130 |
Remaining life (years) | 1 year 1 month 6 days |
Aggregate Intrinsic Value | $ | $ 1,214,544 |
Redemption date | Nov. 13, 2022 |
August 27, 2023 [Member] | |
Number of unvested units | shares | 305,530 |
Remaining life (years) | 1 year 10 months 24 days |
Aggregate Intrinsic Value | $ | $ 525,512 |
Redemption date | Aug. 27, 2023 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|